GlassScriptPhysician profile
Betsy Kay Davis
NPI 1518983857
$2,034.61
in general payments reported to CMS, 2019-2025
20 companies · $323 in 2025
The $323 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2021: $32.13 · 2022: $56.73 · 2023: $1,349 · 2024: $130 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108 · Travel and Lodging: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.09 |
| Travel and Lodging | $693.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $851.03 | 2023 | Na |
| Integra Lifesciences Corporation | $131.29 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Dentsply Sirona INC | $129.40 | 2023 | Implant Dentistry |
| Nobel Biocare USA | $118.76 | 2019 | |
| Forte Bio-Pharma LLC | $116.28 | 2023-2024 | Prolate, Nalocet |
| Southern Implants North America INC | $113.27 | 2023 | |
| Straumann USA LLC | $80.72 | 2025 | |
| Acera Surgical, INC. | $68.44 | 2023-2025 | Restrata Wound Matrix |
| Kulzer, LLC | $62.78 | 2025 | |
| Medtronic, INC. | $50.01 | 2021-2025 | Plasmablade(Tm) |
| Axogen | $49.71 | 2023-2025 | Avance Nerve Graft |
| Regeneron Healthcare Solutions, INC. | $39.17 | 2022 | |
| Organogenesis INC. | $38.56 | 2025 | Affinity |
| Polynovo North America LLC | $32.69 | 2025 | Novosorb Btm |
| Merck Sharp & Dohme LLC | $32.40 | 2023 | Keytruda |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $31.22 | 2025 | |
| Ambu INC. | $30.73 | 2024 | |
| Medtronic USA, INC. | $25.45 | 2019 | |
| Smith+Nephew, INC. | $17.56 | 2022 | |
| Depuy Synthes Sales INC. | $15.14 | 2025 | Matrixmandible, Trumatch, Vivigen Mis Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.